Southeast BIO Forum Features 9 NC companies, Investors, Scientists
The Southeast BIO (SEBIO) Investor & Partnering Forum expects more than 300 biotech and medtech investors, executives, university representatives and entrepreneurs at its 2017 event in Pinehurst November 14 to 16.
Celebrating its 19th year, the SEBIO Investor & Partnering Forum has built a loyal following, attracting thought leaders and investors from across the country. Registration is available at the door.
The event provides slots for inventors, entrepreneurs, and executives to meet Tuesday, Nov. 14 from 9 a.m. to 6 p.m., early-stage mentoring for companies from 2 to 5 p.m., an invitation-only board meeting, and the kick-off reception from 6:30 to 8 p.m.
Wednesday, Nov. 15 opens with a 5K run and a biotech/pharma breakfast from 8 to 9 a.m.
Morning sessions include a panel on regenerative medicine, a medical device breakfast, a corporate partnering event, and a panel on breakout areas.
The North Carolina Biotechnology Center is a partner in sponsoring the event.
Ned David, co-founder of four biotechnology companies that raised more than $1.5 billion and today employ more than 400 people will keynote this year’s Forum during the lunch break. He’ll provide “Dispatches from the Frontiers of Biotechnology.”
UNITY, the company focused on extending human lifespan that he co-founded in 2011, just closed a Series B round with ARCH Venture Partners, Venrock, and Jeff Bezos of Amazon, among other investors.
David was named one of the top 100 innovators in the world under 35 by MIT Technology Review. He co-founded Syrrx, acquired by Takeda; Achaogen; Kythera Biopharmaceuticals, acquired by Allergan, and Sapphire Energy.
Event speakers and panelists include many prominent scientists, investors and executives, including Anthony Atala, Cindy Clark, John Dombrosky, John Glushik, Steven MacDonald, Clay Thorp, Tingling Zhang-Kharas among others.
Afternoon sessions include an Ag/Bio/Microbiome panel, main state company presentations, a Healthcare/IT panel, and the early-stage shootout.
This year, six main-stage and 12 early-stage companies will present their business plans to investors and potential partners. Half of each are from North Carolina.
To date, more than 220 later-stage and 180 early-stage companies that participated in previous SEBIO forums, have raised more than $2.5 billion in public and private funding.
The presenting companies offer novel approaches to treating cancer, precision medicine, medical devices, gene-editing using CRISPR, research tools, quitting smoking, cocaine addiction, food allergies, type 1 diabetes, glaucoma, dry eyes, PAH, smarter instruments for surgeons, and chemotherapy-induced diarrhea, and more.
The Thursday, Nov. 16 sessions start with a look at angel networks in the Southeast and close with a venture capital panel, followed by golfing at the Pinehurst resort.